Handheld project from 4biddenknowledge is intended to support personal wellness awareness through breath-based information and educational feedback
WESTON, FL — [Release Date] — Bell Rose Capital Inc. (OTCID:BELR) (“Bell Rose” or the “Company”) today highlighted development plans for 4BK BioKey™, a handheld breath-analysis project associated with its wholly owned subsidiary, 4biddenknowledge Inc. (“4BK”).
Branded “The Breath of Knowledge,” BioKey is being developed as an educational consumer wellness device. Its intended purpose is to help users explore breath-based information and personal lifestyle patterns through a non-invasive experience.
The proposed platform combines handheld hardware with digital educational tools, bringing a physical-device dimension to 4biddenknowledge’s broader media, education, and technology offerings.
A Focus on Personal Wellness Awareness
Previously announced development plans include guided breath sampling, an onboard display, mobile connectivity, and AI-assisted educational feedback. The proposed companion experience would support viewing trends over time and reflecting on lifestyle patterns.
From Knowledge-Based Media to Consumer Technology
Billy Carson, founder of 4biddenknowledge and identified in Company materials as BioKey’s inventor, has developed a public platform spanning books, streaming programming, podcasts, education, and international experiences.
His books include The Compendium of the Emerald Tablets and Woke Doesn’t Mean Broke. Through 4BK TV and the 4biddenknowledge Podcast, Carson explores ancient history, consciousness, spirituality, and personal empowerment.
BioKey’s proposed educational purpose connects with the platform’s emphasis on making information accessible and encouraging individual exploration. The project would extend that approach into a consumer hardware experience supported by digital content.
Potential Relevance to Bell Rose Shareholders
For Bell Rose shareholders, BioKey represents a prospective expansion into consumer wellness hardware and related digital services.
If successfully developed and commercialized, the project could provide opportunities for device sales and complementary app-based offerings. A connected educational experience could also introduce users to related 4biddenknowledge content and support ongoing engagement.
For shareholders, meaningful future updates would include confirmed development milestones, testing results appropriate to the intended use, manufacturing arrangements, fulfillment readiness, and the commercial terms connecting the project to Bell Rose.
About 4BK BioKey
4BK BioKey™, branded “The Breath of Knowledge,” is a handheld breath-analysis project being developed for educational wellness awareness. Its proposed platform combines breath-based information with digital tools intended to support personal reflection and lifestyle education.
About 4biddenknowledge Inc.
Founded by Billy Carson, 4biddenknowledge Inc. is a media, publishing, education, and technology business. Its offerings include streaming programming, podcasts, books, digital educational content, consumer applications, and live experiences exploring ancient history, consciousness, spirituality, and personal development. 4biddenknowledge is a wholly owned subsidiary of Bell Rose Capital Inc.
About Bell Rose Capital Inc.
Bell Rose Capital Inc. (OTC: BELR) is a publicly traded holding company pursuing the acquisition and development of operating businesses. Through 4biddenknowledge, the Company has operations across digital media, publishing, education, technology, and consumer engagement.
Safe Harbor / Forward-Looking Statements
This release contains forward-looking statements, including statements regarding BioKey’s development, intended educational use, proposed hardware and software capabilities, testing, manufacturing, availability, fulfillment, commercialization, device sales, digital services, and possible benefits to Bell Rose Capital Inc. and its shareholders. Words such as “plans,” “proposed,” “intended,” “would,” “could,” “potential,” and similar expressions identify forward-looking statements.
These statements reflect current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Such risks include engineering and development delays; sensor reliability and performance; testing and substantiation requirements; regulatory classification and applicable compliance obligations; manufacturing quality; component availability; supply-chain disruptions; capital requirements; privacy and data security; intellectual property ownership and contractual rights; consumer acceptance; competition; fulfillment and warranty costs; and risks described in the Company’s public disclosures.
Proposed specifications and timelines may change. The project may be delayed or may not reach commercialization, and potential commercial opportunities may not generate a profit. Forward-looking statements speak only as of the date of this release. The Company undertakes no obligation to update them except as required by applicable law.
Media and Investor Inquiries
Bell Rose Capital Inc.
Investor Relations
IR@bellrosecapitalinc.com
###